azacitidine has been researched along with Uterine Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bulun, SE; Coon V, JS; Dai, Y; Dotts, AJ; Kujawa, SA; Liu, S; Shilatifard, A; Xu, J; Yin, P; Zhao, H | 1 |
An, R; Xu, H; Xue, Y; Zeng, X; Zhang, T; Zhang, Y | 1 |
Beristain, AG; Hogg, K; Robinson, WP | 1 |
3 other study(ies) available for azacitidine and Uterine Neoplasms
Article | Year |
---|---|
Targeting DNA Methylation Depletes Uterine Leiomyoma Stem Cell-enriched Population by Stimulating Their Differentiation.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Count; Cell Differentiation; Cells, Cultured; DNA Methylation; Female; Humans; Leiomyoma; Mice; Mice, SCID; Mice, Transgenic; Middle Aged; Mifepristone; Molecular Targeted Therapy; Neoplastic Stem Cells; Uterine Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
Topics: Animals; Azacitidine; Cell Line, Tumor; Cell Movement; Choriocarcinoma; Decitabine; Dishevelled Proteins; DNA Methylation; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Humans; Matrix Metalloproteinase 2; Membrane Proteins; Mice; Mice, Nude; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Uterine Neoplasms; Wnt Signaling Pathway | 2018 |
Activation of endocrine-related gene expression in placental choriocarcinoma cell lines following DNA methylation knock-down.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aromatase; Azacitidine; Cell Line, Tumor; Choriocarcinoma; CpG Islands; Decitabine; DNA Methylation; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Leptin; Placenta; Pregnancy; Promoter Regions, Genetic; Receptors, Glucocorticoid; TEA Domain Transcription Factors; Transcription Factors; Uterine Neoplasms | 2014 |